Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

262.69 -0.33 (-0.13%)

Streaming Delayed Price Updated: 10:04 AM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

1 Cash-Producing Stock to Target This Week and 2 We Turn Down

September 23, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

September 18, 2025

Via Benzinga

This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗

September 18, 2025

Via Benzinga

This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday ↗

September 18, 2025

Via Benzinga

1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds

September 17, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

September 16, 2025

From Resmed, Inc.

Via GlobeNewswire

Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks

September 11, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at patient monitoring stocks, starting with...

Via StockStory

Topics Artificial Intelligence

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy

Top S&P500 movers in Wednesday's session ↗

September 10, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

September 10, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

September 03, 2025

New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care

From Resmed, Inc.

Via GlobeNewswire

ResMed Inc. (NYSE:RMD): A Top Dividend Stock for Sustainable Income and Growth ↗

September 01, 2025

ResMed (RMD) is a top dividend stock with a low payout ratio, strong financial health, and consistent growth, ensuring sustainable income for investors.

Via Chartmill

2 S&P 500 Stocks to Target This Week and 1 That Underwhelm

August 28, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

3 Reasons Investors Watch ResMed (RMD)

August 28, 2025

ResMed has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.9%. The stock now trades at $281.96, marking a 20.7% gain. This was partly due to its solid...

Via StockStory

Topics Government Stocks

These S&P500 stocks are gapping in today's session ↗

August 27, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

August 27, 2025

Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized care

From Resmed, Inc.

Via GlobeNewswire

1 Mooning Stock to Target This Week and 2 We Brush Off

August 26, 2025

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

August 21, 2025

Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love

From Resmed, Inc.

Via GlobeNewswire

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

August 18, 2025

From Resmed, Inc.

Via GlobeNewswire

RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance

August 12, 2025

Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share...

Via StockStory

Topics Artificial Intelligence Economy

ResMed Inc (NYSE:RMD): A Strong Dividend Stock with Growth Potential and Financial Stability ↗

August 09, 2025

ResMed (RMD) offers a strong dividend with steady growth, backed by solid profitability and financial health, making it ideal for long-term income investors.

Via Chartmill

Discover the top S&P500 movers in Tuesday's pre-market session. ↗

August 05, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

ResMed RMD Q4 2025 Earnings Call Transcript ↗

August 04, 2025

Via The Motley Fool

Topics Earnings

Stay informed with the top movers within the S&P500 index on Monday. ↗

August 04, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

The Analyst Verdict: ResMed In The Eyes Of 8 Experts ↗

August 01, 2025

Via Benzinga

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings ↗

August 01, 2025

Via Benzinga

ResMed (RMD) Stock Is Up, What You Need To Know

August 01, 2025

Shares of medical device company ResMed (NYSE:RMD) jumped 3.1% in the afternoon session after the company reported strong fourth-quarter financial results that surpassed analyst estimates.

Via StockStory

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 01, 2025

Via Benzinga

ResMed (NYSE:RMD) Surprises With Q2 Sales

July 31, 2025

Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above...

Via StockStory

Resmed Inc. (NYSE:RMD) Beats Q4 2025 Revenue and EPS Estimates Despite Muted Market Reaction ↗

July 31, 2025

Resmed Inc. (NYSE:RMD) beats Q4 2025 revenue and EPS estimates, reporting $1.35B and $2.55, respectively. Stock dips slightly amid muted market reaction despite strong growth and dividend hike.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.